Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Small Cell Lung Cancer Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00059722
What this trial is testing

This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC.

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Genzyme, a Sanofi Company 160
Not applicableStudy completedNCT00433602
What this trial is testing

Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
European Organisation for Research and Treatment of Cancer - EORTC 64
Not applicableUnknownNCT04758481
What this trial is testing

Consolidation Conventional Radiotherapy + Stereotactic Body Radiotherapy at 3 Months After First-line Chemotherapy in Stage IV Oligometastatic Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
University Hospital Ostrava 20
Testing effectiveness (Phase 2)UnknownNCT00021008
What this trial is testing

ZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung Cancer

Who this might be right for
Lung Cancer
Jonsson Comprehensive Cancer Center
Large-scale testing (Phase 3)Study completedNCT02477826
What this trial is testing

An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb 2,747
Testing effectiveness (Phase 2)Ended earlyNCT01455389
What this trial is testing

TUSC2-nanoparticles and Erlotinib in Stage IV Lung Cancer

Who this might be right for
Lung Cancer
Genprex, Inc. 25
Early research (Phase 1)Study completedNCT00107250
What this trial is testing

AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)

Who this might be right for
Colorectal CancerLung CancerUnspecified Adult Solid Tumor, Protocol Specific
NCIC Clinical Trials Group 50
Testing effectiveness (Phase 2)Study completedNCT05348668
What this trial is testing

Hybrid Dose-fraction Radiotherapy for Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Anhui Provincial Hospital 78
Testing effectiveness (Phase 2)Study completedNCT00892710
What this trial is testing

Trial of Poor Performance Status Patients (ToPPS)

Who this might be right for
Non Small Cell Lung Cancer
SCRI Development Innovations, LLC 172
Testing effectiveness (Phase 2)Study completedNCT04364620
What this trial is testing

AB-16B5 Combined With Docetaxel in Subjects With Metastatic Non-Small Cell Lung Cancer (EGIA-002)

Who this might be right for
NSCLC Stage IV
Alethia Biotherapeutics 35
Testing effectiveness (Phase 2)Study completedNCT00006004
What this trial is testing

Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00217698
What this trial is testing

Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Swiss Cancer Institute 63
Early research (Phase 1)Study completedNCT01839955
What this trial is testing

Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
Neelesh Sharma MD PhD 12
Large-scale testing (Phase 3)UnknownNCT02633189
What this trial is testing

Study Comparing Bevacizumab + Erlotinib vs Erlotinib Alone as First Line Treatment of Patients With EGFR Mutated Advanced Non Squamous Non Small Cell Lung Cancer

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
National Cancer Institute, Naples 200
Early research (Phase 1)Study completedNCT00162318
What this trial is testing

A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Carcinoma
Eli Lilly and Company 30
Large-scale testing (Phase 3)Study completedNCT00005590
What this trial is testing

Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerExtragonadal Germ Cell Tumor+7 more
Cancer Research Campaign Clinical Trials Centre
Not applicableLooking for participantsNCT05332925
What this trial is testing

Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC

Who this might be right for
Lung CancerNSCLCNSCLC Stage IV
Jun Zhang, MD, PhD 25
Testing effectiveness (Phase 2)Study completedNCT00080938
What this trial is testing

Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerMetastatic Cancer
Eastern Cooperative Oncology Group 26
Large-scale testing (Phase 3)UnknownNCT03083743
What this trial is testing

A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection

Who this might be right for
Non-small-cell Lung Cancer (NSCLC) Stage IV
Shanghai Gebaide Biotechnology Co., Ltd. 417
Large-scale testing (Phase 3)Ended earlyNCT00526643
What this trial is testing

CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients

Who this might be right for
Non-Small Cell Lung Cancer
National Cancer Institute, Naples 57
Next Page